Clinical Trials

Lymphoma, Hematologic Neoplasms

NCT04310592 2024-12-12

CYNK001AML01

27 enrolled

Hematologic Diseases, Leukemia, Leukemia, Myeloid, Neoplasms, Neoplasms by Histologic Type, Leukemia, Myeloid, Acute, Neoplasm, Residual, Hematologic Neoplasms

NCT03648372 2024-11-19

A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System

109 enrolled 54 charts

Lymphoma, Neoplasms, Hematologic Neoplasms

NCT06102213 2024-08-19

Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation

46 enrolled

Hematologic Neoplasms

NCT04305249 2024-07-23

ERASER

36 enrolled

Hematologic Neoplasms

NCT05338346 2024-07-18

ATRIUM

22 enrolled

Hematologic Neoplasms

NCT05100316 2024-02-05

Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials

16 enrolled 5 charts

Neoplasms, Hematologic Neoplasms

NCT05107856 2024-01-31

PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies

LymphoidMyeloidOther hematologic neoplasm

21 enrolled

Lymphoma, Follicular, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT03733249 2023-09-26

Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

187 enrolled 8 charts

Primary Immunodeficiency Diseases, Cytopenia, Anemia, Anemia, Aplastic, Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Thalassemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Anemia, Diamond-Blackfan, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05438498 2023-09-08

Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

Phase 3 Terminated

550 enrolled

COVID-19, Hematologic Neoplasms

NCT04214093 2023-08-02

A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors

LymphoidOther hematologic neoplasmPlasma cell

9 enrolled

Lymphoma, Multiple Myeloma, Recurrence, Tumor Lysis Syndrome, Hematologic Neoplasms

NCT04631211 2023-05-25

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

Classical hematologyMyeloidOther hematologic neoplasm

21 enrolled

Anemia, Aplastic, Myelodysplastic Syndromes, Myeloproliferative Disorders, Thrombocytopenia, Hematologic Neoplasms

NCT04272203 2022-09-08

A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated Cancers

Other hematologic neoplasmThoracic

14 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT04093622 2022-08-29

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

Terminated

Hematologic Neoplasms

NCT02361346 2022-08-18

MT-3724NHL001

38 enrolled 20 charts

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms

NCT02999854 2022-05-24

HATCY

Phase 3 Terminated

63 enrolled 14 charts

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03875495 2022-01-28

A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)

Other hematologic neoplasmPlasma cell

9 enrolled 1 chart

Multiple Myeloma, Hematologic Neoplasms

NCT01627314 2021-11-30

The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.

62 enrolled

Classical hematologyOther hematologic neoplasm

Hematologic Neoplasms

NCT02964325 2021-08-19

MIPLATE

Phase NA Terminated

422 enrolled 24 charts

Thrombocytopenia, Hematologic Neoplasms

NCT00967343 2021-06-14

Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Phase 2/3 Terminated

40 enrolled 10 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Leukemia, Myeloid, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02186821 2021-04-08

SIGNATURE

47 enrolled 13 charts

Lymphoma, B-Cell, Hematologic Neoplasms

NCT01981187 2021-03-26

SIGNATURE

12 enrolled 13 charts

Hematologic Neoplasms

NCT03727009 2021-02-03

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies

Terminated

409 enrolled

Hematologic Neoplasms

NCT03391791 2021-01-07

Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors

Terminated

Neoplasm Metastasis, Hematologic Neoplasms

NCT03135028 2020-03-06

Japanese AML

9 enrolled 10 charts

Recurrence, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT02465528 2019-12-27

Ceritinib Rare Indications Study in ALK+ Tumors

CNSLymphoidOther hematologic neoplasmPlasma cell

22 enrolled 16 charts

Glioblastoma, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic, Hematologic Neoplasms

NCT02679131 2019-11-20

To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.

18 enrolled

Recurrence, Hematologic Neoplasms, Renal Insufficiency

NCT03203369 2019-07-31

ABC123

MyeloidOther hematologic neoplasm

1 enrolled

Blastic Plasmacytoid Dendritic Cell Neoplasm, Hematologic Neoplasms

NCT02160041 2019-06-18

CBGJ398XUS04

84 enrolled 15 charts

Hematologic Neoplasms

NCT02431260 2019-06-14

An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

BreastGastrointestinalLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

69 enrolled 34 charts

Breast Neoplasms, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Colorectal Neoplasms, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms, Primary Myelofibrosis

NCT02895529 2019-05-06

A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy

Phase 4 Terminated

61 enrolled

Hematologic Neoplasms

NCT00957580 2017-08-21

Trial of Pimasertib in Hematological Malignancies

81 enrolled 26 charts

Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT02002689 2016-05-02

SIGNATURE

DermatologicGastrointestinalGynecologicOther hematologic neoplasm

10 enrolled 9 charts

Basal Cell Nevus Syndrome, Colonic Neoplasms, Endometrial Neoplasms, Hematologic Neoplasms

NCT00838890 2015-10-12

A Study of BMS-863233 in Patients With Hematologic Cancer

11 enrolled

Hematologic Neoplasms

NCT01908387 2015-07-28

Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms

NCT00113048 2014-02-05

Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies

24 enrolled

Hematologic Neoplasms

NCT00499239 2014-02-04

A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM)

LymphoidOther hematologic neoplasmPlasma cell

32 enrolled

Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

NCT00387153 2009-11-03

Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer

8 enrolled 7 charts